CEFAZOLINE PANPHARMA 2 g/10 ml, powder and solution for parenteral use (IV) 25 bottles of 2 g
Active ingredients: Cefazolin, Cefazolin sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solution for parenteral use25 bottles of 2 gintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFAZOLINE PANPHARMA 2 g/10 ml, poudre et solution pour usage parentéral (IV)
- Pharmaceutical form
- poudre et solution pour usage parentéral
- Route of administration
- intraveineuse
- Presentation description
- 25 flacon(s) en verre de 2 g
- Marketing authorisation holder
- PANPHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 29 Feb 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67089141CIP75561393CIP133400955613930Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFAZOLINE SODIQUEpoudre | — | SA |
| CÉFAZOLINE BASEpoudre | 2 g · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.